GlassScriptPhysician profile
Leonard Y Lee
NPI 1457448532
$143,040.18
in general payments reported to CMS, 2019-2025
14 companies · $24K in 2025
The $24K reported for 2025 was more than what 94% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,007 · 2020: $19K · 2021: $17K · 2022: $13K · 2023: $23K · 2024: $42K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Travel and Lodging: $20K · Food and Beverage: $9,300 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,150 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,825 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,400.00 |
| Travel and Lodging | $20,159.41 |
| Food and Beverage | $9,300.24 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,150.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,825.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $97,981.45 | 2019-2025 | Mitraclip, Epic, Portico |
| Edwards Lifesciences Corporation | $34,087.73 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Medtronic Vascular, INC. | $3,833.81 | 2019-2020 | |
| Abiomed | $3,043.25 | 2019-2025 | Impella |
| Intuitive Surgical, INC. | $2,313.21 | 2019 | |
| Atricure, INC. | $737.88 | 2019-2024 | |
| Cvrx, INC. | $293.50 | 2021 | |
| Medtronic, INC. | $221.25 | 2021-2024 | Corevalve Evolut R |
| Bolton Medical INC | $138.75 | 2022 | |
| Saranas, INC. | $128.30 | 2021 | |
| Getinge USA Sales, LLC | $97.21 | 2024 | Vasoview Hemopro 2 |
| Cook Medical LLC | $75.47 | 2019 | |
| Lsi Solutions INC | $70.89 | 2025 | Cor-Knot |
| Astrazeneca Pharmaceuticals LP | $17.48 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.